Related Experiment Video
Updated: Feb 14, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Collection of implementation-related data in pragmatic clinical trials: a cross-sectional study from the NIH
Katy E Trinkley1, Shruti Gohil2, Stacie A Salsbury3
1University of Colorado School of Medicine Department of Family Medicine, Anschutz Medical Campus, Aurora, CO, USA. katy.trinkley@cuanschutz.edu.
Background:
Embedded pragmatic clinical trials (ePCTs) are conducted as part of routine care, which provides researchers and health systems multiple opportunities to study implementation processes and outcomes.
Methods:
We conducted a cross-sectional survey of 32 ePCTs associated with the NIH Pragmatic Trials Collaboratory to assess the implementation-related outcomes that were measured or were planned to be measured, including reach (number and percent of eligible patients who participate in an intervention and the representativeness of those patients), patient engagement in or adherence to the intervention, adoption (number and percent of eligible organizations or clinicians that decide to take up or use an intervention), fidelity (clinician's delivery of an intervention as intended), adaptations (changes or modifications to an intervention), sustainability (potential for an intervention to be maintained or institutionalized after a trial concludes), sustainment (actual maintenance or institutionalization of an intervention after a trial concludes), and costs. The trials represented different phases of progress (planned, ongoing, or completed).
Results:
91% of study teams completed the survey, and most (86%) reported measuring reach. The total number of teams measuring other outcomes was 76% for adherence, 45% for clinician adoption, 93% for fidelity, 69% for adaptations, 24% for sustainability, 38% for sustainment, and 31% for costs.
Conclusion:
There is an opportunity for growth in measuring clinician adoption of the intervention, sustainability, sustainment, and associated costs. Measurement of these constructs in future ePCTs could result in development of improved implementation strategies to increase the likelihood of effective implementation leading to equitable, sustainable, and scalable improvement in practice.
More Related Videos
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Cross-Sectional Research
Trial and Error and Algorithm
Data Collection II